DE3650266T2 - DNS-Sequenzen, rekombinante DNS-Moleküle und Verfahren zur Herstellung von "mullerian inhibiting substance"-ähnlichen Polypeptiden. - Google Patents
DNS-Sequenzen, rekombinante DNS-Moleküle und Verfahren zur Herstellung von "mullerian inhibiting substance"-ähnlichen Polypeptiden.Info
- Publication number
- DE3650266T2 DE3650266T2 DE3650266T DE3650266T DE3650266T2 DE 3650266 T2 DE3650266 T2 DE 3650266T2 DE 3650266 T DE3650266 T DE 3650266T DE 3650266 T DE3650266 T DE 3650266T DE 3650266 T2 DE3650266 T2 DE 3650266T2
- Authority
- DE
- Germany
- Prior art keywords
- polypeptides
- production
- methods
- inhibiting substance
- dna sequences
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/792,880 US5047336A (en) | 1985-10-30 | 1985-10-30 | DNA sequences, recombinant DNA molecules and processes for producing mullerian inhibiting substance-like polypeptides |
Publications (2)
Publication Number | Publication Date |
---|---|
DE3650266D1 DE3650266D1 (de) | 1995-04-20 |
DE3650266T2 true DE3650266T2 (de) | 1995-08-31 |
Family
ID=25158349
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE3650266T Expired - Lifetime DE3650266T2 (de) | 1985-10-30 | 1986-10-29 | DNS-Sequenzen, rekombinante DNS-Moleküle und Verfahren zur Herstellung von "mullerian inhibiting substance"-ähnlichen Polypeptiden. |
Country Status (13)
Country | Link |
---|---|
US (1) | US5047336A (de) |
EP (1) | EP0221761B1 (de) |
JP (2) | JPH0720431B2 (de) |
KR (1) | KR870004143A (de) |
AT (1) | ATE119915T1 (de) |
AU (1) | AU606584B2 (de) |
CA (1) | CA1307753C (de) |
DE (1) | DE3650266T2 (de) |
DK (1) | DK517986A (de) |
HU (1) | HUT43627A (de) |
IL (1) | IL80451A0 (de) |
PT (1) | PT83655B (de) |
ZA (1) | ZA868251B (de) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5047336A (en) * | 1985-10-30 | 1991-09-10 | Biogen, Inc. | DNA sequences, recombinant DNA molecules and processes for producing mullerian inhibiting substance-like polypeptides |
EP0437427A4 (en) * | 1985-10-30 | 1992-07-01 | Biogen, Inc. | Cleaved dimers of mullerian inhibiting substance-like polypeptides |
US5427780A (en) * | 1985-10-30 | 1995-06-27 | Biogen, Inc. | Composition comprising Mullerian inhibiting substance-like polypeptides |
US5185441A (en) * | 1988-08-26 | 1993-02-09 | Biogen, Inc. | Dna sequences, recombinant dna molecules and processes for producing pi-linked lymphocyte function associated antigen-3 |
US5661126A (en) * | 1989-01-19 | 1997-08-26 | The General Hospital Corporation | Use of mullerian inhibiting substance for treating certain tumors and for modulating class I major histocompatibility antigen expression |
US5349058A (en) * | 1990-02-06 | 1994-09-20 | E. R. Squibb & Sons, Inc. | Nucleic acid encoding human mevalonate kinase |
US5281520A (en) * | 1990-09-12 | 1994-01-25 | Zymogenetics, Inc. | Method for producing acyloxyacyl hydrolase |
US5310880A (en) * | 1991-04-12 | 1994-05-10 | The General Hospital Corporation | Purification of Mullerian inhibiting substance |
US6764681B2 (en) * | 1991-10-07 | 2004-07-20 | Biogen, Inc. | Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the CD2/LFA-3 interaction |
AU3920693A (en) * | 1992-03-18 | 1993-10-21 | General Hospital Corporation, The | Four novel receptors of the TGF-beta receptor family |
EA005948B1 (ru) * | 1998-08-31 | 2005-08-25 | Байоджен, Инк. | Применение cd2-связывающего агента для избирательного снижения числа cd45ro-позитивных эффекторных т-лимфоцитов памяти в организме пациента |
US20020119921A1 (en) * | 1999-03-31 | 2002-08-29 | Michael Streit | Thrombospondin-2 and uses thereof |
EP1218025A4 (de) * | 1999-09-14 | 2005-06-01 | Gen Hospital Corp | Verwendung von müllerscher inhibierender substanz zur behandlung von androgenüberschuss zuständen |
AU2001231196A1 (en) | 2000-01-27 | 2001-08-07 | The General Hospital Corporation | Delivery of therapeutic biological from implantable tissue matrices |
JP2005525081A (ja) * | 2001-06-05 | 2005-08-25 | カレン ケイ. オオイシ | 植物からの生物活性ミュラー管抑制物質を含むTGF−βタンパク質の遺伝子発現および産生法 |
US7858095B2 (en) * | 2001-07-24 | 2010-12-28 | Astellas Us Llc | Method for treating or preventing sclerotic disorders using CD-2 binding agents |
WO2004017919A2 (en) * | 2002-08-23 | 2004-03-04 | The General Hospital Corporation | Use of mullerian inhibiting substance and interferon for treating tumors |
CA2555144A1 (en) * | 2004-02-06 | 2005-08-25 | Astellas Us Llc | Methods of treating skin disorders |
BRPI0510691A (pt) * | 2004-05-04 | 2007-12-26 | Genaissance Pharmaceuticals | marcadores de haplótipos e métodos de uso dos mesmos para determinar resposta ao tratamento |
WO2005115436A1 (en) * | 2004-05-07 | 2005-12-08 | Astellas Us Llc | Soluble lfa-3 polypeptide for treating viral disorders |
WO2006118617A2 (en) * | 2004-12-23 | 2006-11-09 | Chlorogen, Inc. | EXPRESSING TGF-β PROTEINS IN PLANT PLASTIDS |
AU2005211556A1 (en) * | 2005-03-24 | 2006-10-12 | Otago Innovation Limited | Method Of Modulation |
WO2007049977A2 (en) * | 2005-10-26 | 2007-05-03 | Otago Innovation Limited | Method of modulation of mullerian inhibitory substance (mis) receptor for the treatment of neurodegenerative diseases. |
WO2008116161A2 (en) * | 2007-03-22 | 2008-09-25 | The General Hospital Corporation | Pyrazoloanthrone and derivatives thereof for the treatment of cancer expressing 'mullerian inhibiting substance' type ii receptor (misrii) and of excess androgen states |
EP2190481B1 (de) | 2007-07-17 | 2014-12-24 | The General Hospital Corporation | Verfahren zur identifizierung und anreicherung von populationen von eierstockkrebs-stammzellen und somatischen eierstock-stammzellen und ihre verwendungen |
ITRM20120285A1 (it) | 2012-06-18 | 2013-12-19 | Alfonso Baldi | Ormone anti-mulleriano. |
EP2968470B1 (de) * | 2013-03-12 | 2020-10-28 | The General Hospital Corporation | Modifizierte proteine mit einer müllerschen hemmersubstanz und verwendungen davon zur behandlung von krankheiten |
RU2616273C1 (ru) * | 2016-04-21 | 2017-04-13 | Федеральное государственное унитарное предприятие "Государственный научно-исследовательский институт особо чистых биопрепаратов" Федерального медико-биологического агентства | Синтетическая ДНК, кодирующая антимюллеров гормон человека, содержащий ее экспрессионный вектор pTVK4pu/MISOPT и штамм клеток яичников китайского хомячка CHO-MIS - продуцент рекомбинантного антимюллерового гормона человека |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4404188A (en) * | 1981-07-29 | 1983-09-13 | Massachusetts General Hospital | Purified Mullerian Inhibiting Substance and method of purification |
US4510131A (en) * | 1981-07-29 | 1985-04-09 | The General Hospital Corporation | Purified Mullerian Inhibiting Substance and method of use |
US4442205A (en) * | 1981-09-22 | 1984-04-10 | The United States Of America As Represented By The Department Of Health And Human Services | Simian virus recombinant that directs the synthesis of hepatitis B surface antigen |
US4487833A (en) * | 1982-03-01 | 1984-12-11 | The General Hospital Corporation | Method of preparing hybridomas and of purifying immunogenic materials |
US4740587A (en) * | 1985-07-18 | 1988-04-26 | The Salk Institute For Biological Studies | Inhibin and method of purifying same |
US5047336A (en) * | 1985-10-30 | 1991-09-10 | Biogen, Inc. | DNA sequences, recombinant DNA molecules and processes for producing mullerian inhibiting substance-like polypeptides |
-
1985
- 1985-10-30 US US06/792,880 patent/US5047336A/en not_active Expired - Fee Related
-
1986
- 1986-10-29 DK DK517986A patent/DK517986A/da not_active Application Discontinuation
- 1986-10-29 AU AU64521/86A patent/AU606584B2/en not_active Expired
- 1986-10-29 ZA ZA868251A patent/ZA868251B/xx unknown
- 1986-10-29 CA CA000521767A patent/CA1307753C/en not_active Expired - Lifetime
- 1986-10-29 HU HU864535A patent/HUT43627A/hu unknown
- 1986-10-29 AT AT86308400T patent/ATE119915T1/de not_active IP Right Cessation
- 1986-10-29 EP EP86308400A patent/EP0221761B1/de not_active Expired - Lifetime
- 1986-10-29 DE DE3650266T patent/DE3650266T2/de not_active Expired - Lifetime
- 1986-10-30 IL IL80451A patent/IL80451A0/xx unknown
- 1986-10-30 KR KR860009203A patent/KR870004143A/ko not_active Application Discontinuation
- 1986-10-30 JP JP61257126A patent/JPH0720431B2/ja not_active Expired - Fee Related
- 1986-10-30 PT PT83655A patent/PT83655B/pt unknown
-
1993
- 1993-07-19 JP JP5178268A patent/JP2541761B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
KR870004143A (ko) | 1987-05-07 |
JPS62190084A (ja) | 1987-08-20 |
DK517986D0 (da) | 1986-10-29 |
IL80451A0 (en) | 1987-01-30 |
HUT43627A (en) | 1987-11-30 |
JPH06133793A (ja) | 1994-05-17 |
ZA868251B (en) | 1988-09-28 |
PT83655A (en) | 1986-11-01 |
JP2541761B2 (ja) | 1996-10-09 |
PT83655B (en) | 1988-11-29 |
EP0221761B1 (de) | 1995-03-15 |
EP0221761A3 (en) | 1988-10-12 |
US5047336A (en) | 1991-09-10 |
DE3650266D1 (de) | 1995-04-20 |
DK517986A (da) | 1987-05-01 |
EP0221761A2 (de) | 1987-05-13 |
JPH0720431B2 (ja) | 1995-03-08 |
AU6452186A (en) | 1987-05-07 |
AU606584B2 (en) | 1991-02-14 |
ATE119915T1 (de) | 1995-04-15 |
CA1307753C (en) | 1992-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3650266D1 (de) | DNS-Sequenzen, rekombinante DNS-Moleküle und Verfahren zur Herstellung von "mullerian inhibiting substance"-ähnlichen Polypeptiden. | |
ATE113295T1 (de) | Tumornekrosefaktor, verfahren zu seiner herstellung, denselben enthaltende zusammensetzungen, dafür kodierende dns und diese dns verwendendes testverfahren. | |
JPS55104887A (en) | Rearranged dna molecule and method | |
ES8400770A1 (es) | Un metodo para producir una molecula de adn recombinante caracterizada por una secuencia de adn codificada de un coni- peptido semejante al, interferon humano. | |
EP0088540A3 (de) | DNS-Sequenzen, Rekombinante DNS-Moleküle und Verfahren zur Herstellung von dem immunen menschlichen Interferon ähnlichen Polypeptiden | |
DE69131580T2 (de) | GDF-1 und UOG1 Proteine | |
BR8301918A (pt) | Proteina,sequencia de dna,veiculo de expressao replicavel,microorganismo ou cultura celular,plasmideo,composicao,cultura de celulas,utilizacao de tal proteina,processo de expressao,processo para producao de um veiculo de expressao e processo para preparacao de uma proteina uroquinase | |
ES2155819T3 (es) | Inmunoglobulinas hibridas. | |
ATE295889T1 (de) | Gentranskription und ionisierende strahlung: methoden und zusammensetzungen | |
ATE49233T1 (de) | Vektoren zur transformation von hefe. | |
HUT46061A (en) | Dna sequences encoding hirudin-like protein and process for producing such proteins | |
MD430C2 (ro) | Procedeu de obţinere a interferonelor leucocitare umane | |
NO179412C (no) | Hybrid DNA-molekyl som koder for fibronektinbindende protein, mikroorganismer inneholdende slike DNA-molekyler samt fremgangsmåte ved fremstilling av slikt protein | |
ZA86217B (en) | Dna sequences,recombinant dna molecules and processes for producing human lipocortin-like polypeptides | |
ES8506347A1 (es) | Un metodo para producir un polipeptido de tipo il-2-". | |
DE69013811T2 (de) | Verfahren zur Herstellung von antiviralem Protein unter Benützung von E.coli-Transformant, das Gen, das für dieses Protein kodiert und E.coli-Vektor benützt in diesem Verfahren. | |
ES8706827A1 (es) | Procedimiento para preparar polipeptidos. | |
GR3034725T3 (en) | Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy. | |
DE68910036T2 (de) | Luciferase-Gen und neue rekombinante DNA sowie Verfahren zur Herstellung von Luciferase. | |
ZA84512B (en) | Dna sequences,recombinant dna molecules and processes for producing human interleukin two-like polypeptides | |
MY102686A (en) | Recombinant dna molecules and their method of production. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |